MLTXMoonLake Immunotherapeutics Class A Ordinary Shares

CSNasdaq (XNAS)·USD

Identity

Security key: 18632
Ticker: MLTX
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2022-04-06
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: MLTX

Detail

Enriched 2026-08-14 20:47

Market cap: $1,466,388,182.55
Shares outstanding (class): 73,615,396
Shares outstanding (weighted): 85,106,685
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 130
Location: ZUG, V8
Homepage: https://www.moonlaketx.com
Description: MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.

Market cap and share counts drift.

Funds holding this security

15 funds · 17 positions · $23.43M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC.	—	$16.53M	0.15%	887,029 NS	FIGI
JNL Multi-Manager Small Cap Value Fund JNL Series Trust	—	$2.04M	0.12%	109,447 NS	FIGI
Nomura Healthcare Fund Delaware Group Equity Funds IV	—	$1.49M	0.22%	80,000 NS	FIGI
T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC.	—	$1.01M	0.15%	54,070 NS	FIGI
BlackRock Health Sciences Term Trust —	—	$523.9K	0.05%	28,105 NS	FIGI
Optimize Strategy Index ETF Advisor Managed Portfolios	OPTZ	$455.2K	0.22%	24,419 NS	FIGI
Health Sciences Trust John Hancock Variable Insurance Trust	—	$398.6K	0.18%	21,385 NS	FIGI
EQ/T.Rowe Price Health Sciences Portfolio EQ Advisors Trust	—	$304.8K	0.19%	16,351 NS	FIGI
T. Rowe Price Health Care ETF T. Rowe Price Exchange-Traded Funds, Inc.	TMED	$181.2K	0.89%	9,719 NS	FIGI
BlackRock Advantage SMID Cap Fund, Inc. BlackRock Advantage SMID Cap Fund, Inc.	—	$127.4K	0.02%	6,836 NS	FIGI
BlackRock Health Sciences Trust —	—	$110.1K	0.02%	5,908 NS	FIGI
Health Sciences Portfolio PACIFIC SELECT FUND	—	$73.9K	0.02%	3,966 NS	FIGI
Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds	—	$70.8K	0.00%	3,800 NS	FIGI
JNL/DFA U.S. Small Cap Fund JNL Series Trust	—	$43.0K	0.01%	2,307 NS	FIGI
Clearwater Select Equity Fund Clearwater Investment Trust	—	$36.9K	0.01%	1,977 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERMLTX
FIGI_COMPOSITEBBG00XQZQTS9
FIGI_SHARE_CLASSBBG00XQZQVP7
CIK0001821586
ISINKY61559X1045
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: MoonLake Immunotherapeutics is a biopharmaceutical company developing antibody therapies, classified under pharmaceutical preparations.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.